Transient hemolytic anemia after kidney transplantation and thrombotic thrombocytopenic purpura refractory to plasma exchange and rituximab

Renal Failure

Volumn 31, Issue 5, 2009, Pages 419-420

  Pieringer, Herwig ^a   Schmekal, Bernhard ^a   Gruber, Franz ^a   Vosko, Milan R ^a   Biesenbach, Georg ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; CASE REPORT; CORTICOSTEROID THERAPY; DEATH; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULONEPHRITIS; HEMOLYTIC ANEMIA; HEMORRHAGIC SHOCK; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANEMIA, HEMOLYTIC; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHOCK, HEMORRHAGIC; TREATMENT FAILURE;

EID: 70849113812     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220902839121     Document Type: Letter

References (12)

1. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion. 2004;44:294-304.
2. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Intern Med. 1998;129:886-890.
3. Crew RJ, Radhakrishnan J, Cohen DJ, Stern L, Goldstein M, Hardy M, D'Agati VD, Markowitz GS. De novo thrombotic microangiopathy following treatment with sirolimus: Report of two cases. Nephrol Dial Transplant. 2005;20:203-209.
4. Pham PT, Danovitch GM, Wilkinson AH, Gritsch HA, Pham PC, Eric TM, Kendrick E, Charles LR, Tsai HM. Inhibitors of ADAMTS13: A potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient. Transplantation. 2002;74:1077-1080.
5. Moake JL. Thrombotic thrombocytopenic purpura: Survival by "giving a dam." Trans Am Clin Climatol Assoc. 2004; 115:201-219.
6. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102:60-68.
7. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98: 2730-2735.
8. Ozdogu H, Boga C, Kizilkilic E, Yeral M, Kozanoglu I, Karatas M. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke. J Thromb Thrombolysis. 2007; 23:147-150.
9. Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol. 2007;136: 451-461.
10. Gallerani E, Lerch E, Romagnani E, Stathis A, Giardelli G, Zwhalen H, Marone C, Cavalli F. Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol. 2006;77:527-529.
11. Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA. Rituximab for acute plasmarefractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Swiss Med Wkly. 2007 Sep 22;137(37-38):518-524.
12. Li X, Hunt L, Vesely SK. Drug-induced thrombocytopenia: An updated systematic review. Ann Intern Med. 2005;142: 474-475.